Novaliq (Germany)

Recent papers from Novaliq (Germany)

1. Magnetic resonance elastography of brain tumorsZeitschrift für Medizinische Physik · 2026
2. Ocular Pharmacokinetics and Biodistribution of Perfluorohexyloctane after Topical Administration to RabbitsJournal of Ocular Pharmacology and Therapeutics · 2025
3. Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye diseaseGraefe s Archive for Clinical and Experimental Ophthalmology · 2024
4. Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trialsFrontiers in Ophthalmology · 2024
5. Ophthalmological research in Germany: suggestions by an international expert panelDeleted Journal · 2024
6. Long-Term Safety and Efficacy of a Water-Free Cyclosporine 0.1% Ophthalmic Solution for Treatment of Dry Eye Disease: ESSENCE-2 OLECornea · 2024
7. Water-Free Cyclosporine Ophthalmic Solution vs Vehicle for Dry Eye DiseaseJAMA Ophthalmology · 2024
8. Efficacy of a Novel Water-Free Topical Cyclosporine 0.1 % Solution for Optimizing the Ocular Surface in Patients with Dry Eye and CataractJournal of Cataract & Refractive Surgery · 2024
9. Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI StudyCornea · 2023
10. Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye DiseaseJAMA Ophthalmology · 2023
11. NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE StudyAmerican Journal of Ophthalmology · 2023
12. Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese PatientsJAMA Ophthalmology · 2023
13. NOV03 for Dry Eye Disease Associated with Meibomian Gland DysfunctionOphthalmology · 2022
14. A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE StudyCornea · 2021
15. A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye DiseaseCornea · 2020
16. VEGF TrapR1R2 Suspended in the Semifluorinated Alkane F6H8 Inhibits Inflammatory Corneal Hem- and LymphangiogenesisTranslational Vision Science & Technology · 2020
17. Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical TrialJournal of Ocular Pharmacology and Therapeutics · 2020
18. CRF1 Receptor Signaling via the ERK1/2-MAP and Akt Kinase Cascades: Roles of Src, EGF Receptor, and PI3-Kinase MechanismsFrontiers in Endocrinology · 2019
19. Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional StudyOphthalmic Research · 2019
20. A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye DiseaseOphthalmology · 2019